The identification of disease markers in human body fluids requires an extensive and thorough analysis of its protein constituents. In the present study, we have extended our analysis of the human cerebrospinal fluid (CSF) proteome using protein prefractionation followed by shotgun mass spectrometry. After the removal of abundant protein components from the mixture with the help of immunodepletion affinity chromatography, we used either anion exchange chromatography or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to further subfractionate the proteins present in CSFs. Each protein subfraction was enzyme digested and analyzed by tandem mass spectrometry and the resulting data evaluated using the Spectrum Mill software. Different subfractionation methods resulted in the identification of a grant total of 259 proteins in CSF from a patient with normal pressure hydrocephalus. The greatest number of proteins, 240 in total, were identified after prefractionating the CSF proteins by immunodepletion and SDS-PAGE. Immuno-depletion combined with anion exchange fractionation resulted in 112 proteins and 74 proteins were found when only immunodepletion of the CSF sample was carried out. All methods used showed a significant increase in the number of identified proteins as compared with nondepleted and unfractionated CSF sample analysis, which yielded only 38 protein identifications. The present work establishes a platform for future studies aimed at a detailed comparative proteome analysis of CSFs from different groups of patients suffering from various psychiatric and neurological disorders.
Introduction
A study by the World Health Organization has found that diseases of the central nervous system are affecting a significant portion of the population and are among the leading causes of death in Western societies (1) . Although great advances have been made in our understanding of the pathophysiology of psychiatric and neurological diseases, significant gaps remain in our knowledge about their ultimate causes.
Because it constantly perfuses brain tissue, cerebrospinal fluid (CSF) represents a lavage of sorts and hence contains mediators that reflect metabolic processes in the brain. In this regard, it is likely that CSF contains proteins that are secreted or shed from brain cells and can therefore be used for diagnostic purposes to analyze and quantify proteins and peptides derived from the brain. Furthermore, CSF can be obtained in a controlled fashion, minimizing the dangers of variability introduced at the sample collection step. For these reasons, CSF has been used for the analysis of specific proteins in screening several psychiatric and neurological disorders by various immunoassays (2) . It is hypothesized that the changes in CSF proteins reflect the pathological alterations in the function of the central nervous system. Therefore, the comparative analysis of the proteomes of human CSF from diseased and healthy subjects is becoming increasingly important for the identification of diseasespecific proteins. It is hoped that these studies will ultimately result in the discovery of novel markers of disease and suggest mechanisms and treatments for psychiatric and neurological disorders. For this purpose, CSF samples from healthy subjects and patients with psychiatric and neurological diseases can be compared using various proteomic methods. In addition, CSF samples from patients before and after treatment with specific drugs may be able to reveal important differences in an individual's response to a certain drug treatment and lead to personalized medicine approaches. Hence, it is hoped that protein profiling of CSF will ultimately result in a better understanding of disease mechanisms and the molecular effects of drugs.
The analysis of entire proteomes from a clinical specimen is by no means straightforward (3) . The major hurdle when it comes to patient samples is the limiting amount of starting material that is available to carry out the analysis. Clinical samples, such as body fluids, frequently cannot be obtained in large enough amounts. The other reason that the analysis of the proteome in CSF is difficult is because of the large dynamic range of protein concentrations in such fluids, which can be up to 12 orders of magnitude between the highest and lowest expressed proteins (3) . This range of protein concentrations exceeds the current capabilities of proteomic analysis and is a major barrier in the identification of low abundant proteins in body fluids. Further complicating the analysis of CSF is the possible infiltration of serum proteins that is caused by a leaky blood-brain barrier that is especially pronounced in patients with brain disorders. As a consequence, it is often impossible to know if a protein that is found in CSF is derived from the brain or serum.
Proteome analysis in general involves two stages: protein separation followed by identification and analysis. Multidimensional separations are required in order to result in an adequate resolution of complex protein mixtures in body fluids. Classical proteomic approaches use fractionation on the protein level with the help of two-dimensionalpolyacrylamide gel electrophoresis (2D-PAGE) (4, 5) . This technique produces high-resolution protein separations resulting in the display of potentially thousands of protein spots. Alternatively, tryptic peptides derived from the proteins in the mixture can be subjected to shotgun mass spectrometry analysis. In the shotgun mass spectrometry approach, proteins are digested by specific enzymes into small peptides and analyzed on-line by mass spectrometry (6) . A major advantage of the shotgun mass spectrometry approach is that low abundant proteins can be identified in the presence of high abundant proteins, a scenario that is often encountered when analyzing protein mixtures from body fluids like serum or CSF (3) .
In a previous study, we have described our attempts to identify a large number of the constituents of the human CSF proteome (7) using the shotgun mass spectrometry methodology (8) . This was achieved by depletion of the most abundant proteins from the mixture with the help of an immunoaffinity column and subsequent multidimensional fractionation of the peptides resulting from an Endoproteinase Lys-C, trypsin double digest of the remaining proteins and shotgun mass spectrometry analysis. In the present study, we have extended the human CSF proteome analysis by using prefractionation of the immunodepleted sample on the protein level. Using anion exchange chromatography (AEC) or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for protein separation, we have been able greatly increase the number of CSF proteins identified. The described indepth CSF proteome analysis will greatly assist our efforts to identify biomarkers for psychiatric and neurological disorders.
Materials and Methods

Collection of Human CSF
With the subject in the sitting position, lumbar puncture was performed at the fourth lumbar intervertebral space using an atraumatic needle without local anesthesia. For this study, CSF from a patient with normal pressure hydrocephalus was used. In order to remove cellular debris, we centrifuged the CSF sample and then aliquoted and transferred it to a Ϫ80°C freezer. The CSF sample used for the studies had the following protein concentrations: total protein 266 g/mL, human serum albumin (HSA) 158 g/mL, immunoglobulin (Ig)G 22.2 g/mL.
Immunodepletion
A total of 6 mL CSF from a patient with normal pressure hydrocephalus was thawed on ice and concentrated to 100 µL on a Vivaspin 5-kDa cartridge (Vivascience AG, Hannover, Germany) by centrifugation at 2380g at 4°C. This cartridge retains proteins with a molecular mass >5 kDa; at the same time, it removes salts and other low-molecularweight compounds.
The Vivaspin retentate was washed with 1 mL of buffer A (phosphate salt solution, pH 7.4, containing 0.02% NaN 3 ; Agilent Technologies, Wilmington, DE). This step was repeated three times and the sample concentrated to a final volume of 100 µL. Fifty-microliter aliquots of the concentrated CSF sample were then loaded onto the Multiple Affinity Removal System immuno affinity column, 0.46 ϫ 50 mm (Agilent Technologies). The Multiple Affinity Removal System column removed the following proteins from the CSF mixture: HSA, transferrin, haptoglobin, IgG, IgA, and antitrypsin. During the immunoaffinity high-pressure liquid chromatography (HPLC) run, the column effluents were monitored at 280 nm with a flow rate of 250 µL/min for sample loading and collection of the flow-through fraction. For column elution, the flow was increased to 1 mL/min. Typically, the flowthrough fraction containing the depleted CSF protein mixture eluted in a volume of 1.5-2 mL. Elution of the absorbed proteins was carried out with a urea buffer at pH 2.5 (Buffer B; Agilent Technologies) at a flow rate of 1 mL/min.
Sample Preparation for Direct Shotgun Mass Spectrometry
The immunoaffinity column flow-through fraction was concentrated on a Vivaspin 5-kDa cartridge (Vivascience AG) as described above, washed three times with 1 mL 200 mM NH 4 HCO 3 at pH 8.5 and concentrated to a final volume of 50 L. For digestion, the sample was adjusted to 8M urea and proteins reduced with 10 mM dithiothreitol (DTT) at 37°C in the dark for 1 h and alkylated with 50 mM iodoacetamide at 37°C in the dark for 30 min. The sample was then diluted to 2 M urea with 200 mM NH 4 HCO 3 at pH 8.5 and digested with 10 µg Endoproteinase Lys-C (Roche Diagnostics, Indianapolis, IN) at 37°C overnight. The next day, 10 µg of trypsin (Promega, Madison, WI) was added and the incubation continued at 37°C overnight. The treatment with two enzymes leads to a more efficient digestion of the substrate proteins. In addition, peptide bonds after lysine residues that are preceded by a proline residue are not cleaved by trypsin but are amenable to cleavage with Endoproteinase Lys-C.
After digestion, salts were removed by using a SPEC Plus PT pipette tip solid phase extraction cartridge (Varian Inc., Palo Alto, CA) according to the manufacturer's instructions. Peptides were eluted from the SPEC cartridge with two aliquots of 20 µL 95% acetonitrile, 0.1% formic acid. Finally, the acetonitrile was removed by vacuum centrifugation and the remaining mixture dissolved in 40 µL 5 mM KH 2 PO 4 , 25% acetonitrile at pH 3.0.
Anion Exchange Chromatography
The depleted CSF sample was washed three times with 20 mM Tris-HCl at pH 8.0, using a Vivaspin 5-kDa cartridge (Vivascience AG) as described above and concentrated to 100 µL. The sample was then manually loaded onto a strong anion exchange macro trap cartridge, 3 ϫ 8 mm (Michrom BioSources, Inc., Auburn, CA). Proteins were eluted with 100 µL 20 mM Tris-HCl, pH 8.0, buffer containing 20 mM, 50 mM, 100 mM, 150 mM, 200 mM, 300 mM, 400 mM, and 500 mM of NaCl. The eluted fractions were collected and concentrated and washed three times with 200 mM NH 4 HCO 3 at pH 8.5 to a final volume of 50 µL with a Vivaspin 5-kDa cartridge (Vivascience AG) as described above. The protein mixtures from the eight salt fractions were adjusted to 8 M urea and reduced and alkylated as described above. The samples were then diluted to 2 M urea with 200 mM NH 4 HCO 3 at pH 8.5 and digested and processed as described above.
SDS-Polyacrylamide Gel Electrophoresis
The depleted CSF was washed three times with 200 mM NH 4 HCO 3 at pH 8.5, concentrated to 50 µL with a Vivaspin 5-kDa (Vivascience AG) cartridge, and reduced and alkylated as described above. The dried sample was dissolved in 30 µL of SDS sample buffer (125 mM Tris-HCl, pH 8.0, 9.2% SDS, 0.39 M DTT, 40% glycerol, 0.001% bromophenol blue) and loaded onto a 12% SDS polyacrylamide gel using a Protean Plus Cell apparatus (Bio-Rad Laboratories, Hercules, CA). After electrophoresis, the proteins were stained with colloidal Coomassie Blue and scanned with a densitometer (Bio-Rad Laboratories). The protein-containing gel lane was cut in 5 ϫ 1 mm slices, which were destained two times with 70 µL acetonitrile/20 mM NH 4 HCO 3 at pH 8.5 (1:1) at 37°C for 30 min and then dried under a fume hood. For digestion, 1 µg trypsin in 30 µL 20 mM NH 4 HCO 3 at pH 8.5 was added to each gel slice. The enzymatic reaction was carried out at 37°C overnight. After the digestion, the peptides were extracted by adding 5% formic acid at 37°C for 30 min. The gel pieces were spun down and the liquid collected. The extraction was repeated twice. Finally, the extracted digest peptide mixture was lyophilized to dryness and dissolved in 12 µL 0.1% formic acid.
Mass Spectrometry Analysis Strong Cation Exchange Chromatography
After digestion and desalting, the CSF digest peptide mixture was loaded onto an SCX cation exchange column, 0.5 ϫ 15 mm (Dionex, Sunnyvale, CA) that had been equilibrated in 5 mM KH 2 PO 4 , 25% acetonitrile at pH 3.0 at a flow rate of 30 µL/min. After washing the column with buffer A for 5 min, peptides were eluted by applying a linear gradient from 0 to 50% of 25% acetonitrile, 350 mM KCl at pH 3.0. Fractions were collected at 1-min intervals and lyophilized to dryness. The peptides were then dissolved in 36 µL 0.1% formic acid.
Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) Analysis
One-third of each cation exchange fraction (12 µL) was loaded onto a PicoFrit RP-C18 column, 0.075 ϫ 10 mm (New Objective Inc., Woburn, MA) in 0.1% formic acid (solvent A1), washed with solvent A1 for 15 min, and eluted with a linear gradient of 95% acetonitrile/0.1% formic acid (solvent B1) over 90 min at a flow rate of 200 nL/min using the ULTIMATE nano-HPLC system (Dionex). Column effluents were directly infused into an LCQ DECA XP PLUS iontrap mass spectrometer (Thermo Electron Corp., San Jose, CA). For mass spectrometry analysis, three separate runs were carried out for each cation exchange fraction. In each run, the four most abundant precursor ions were subjected to fragmentation and MS/MS analysis. Different mass/charge (m/z) limits were used for the full scan in each run (400-900, 900-1500, 1500-2000). The mass spectrometer was operated with an ion spray voltage of 1.1 kV, a normalized collision energy of 35%, a default charge state of +3, an isolation width of 4 amu, a reject mass width of 0.5, a dynamic exclusion of 3 min, an exclusion mass width of 3 amu, a repeat count of 2, and a repeat duration of 0.35 min.
Data Analysis
All MS/MS spectra were processed and analyzed using the Spectrum Mill software and default parameters (Agilent Technologies, Santa Clara, CA) (9) . After the extraction step during which MS/MS spectra of low quality were removed, the spectra were searched against the human international protein index (IPI) database, version 2.29, 03/05/2004 (EBI, Cambridgeshire, UK) with the static chemical modification of +57 Dalton (Cyscarboxyamidomethyl) and a precursor ion accuracy of 3 Dalton. For a protein identification to be autovalidated in Spectrum Mill, the protein needs to have a score (sum of peptide scores that map to that protein) of >20. For a "one-hit wonder" to pass Spectrum Mill's autovalidation routine, in peptide validation mode, the peptide must have a score of 13 or greater. In addition, using the same parameters, all MS/MS spectra were also searched against a reversed human IPI database in order to assess the frequency of false-positive hits.
Results and Discussion
A major hurdle of the proteome analysis of body fluids such as CSF is the rather large dynamic range of the proteins present in the mixture. It is estimated that in CSF and serum the range of protein concentrations spans 12 orders of magnitude (3) . As a consequence, the identification of proteins lower in concentration than the very abundant HSA and Ig is extremely difficult. To circumvent the problem caused by the large dynamic range of protein expression, several approaches have been developed that will deplete the most abundant proteins from body fluids. In our previous studies, we have shown that an immunoaffinity matrix that is made up of affinity-purified polyclonal antibodies against the six major proteins in serum (HSA, transferrin, haptoglobin, IgG, IgA, and antitrypsin) also removes the six most abundant proteins from CSF and thereby allows the identification by mass spectrometry of a great number of low abundant proteins in CSF (7) . Because of its great specificity, we have been using the Multiple Affinity Removal System for all our subsequent studies that are geared toward an in-depth proteome analysis of human CSF.
CSF from a patient with normal pressure hydrocephalus was used for all our studies because of the relatively large volume of fluid that can be obtained. This is critical because it allows one to perform several experiments with the same CSF sample whose results can be compared for proteomic method development.
In our previous CSF proteomic studies, we used immunodepletion followed by shotgun mass spectrometry analysis of the peptide (7) . In order to extend our proteome mining efforts and increase the number of identified proteins, we reasoned that further fractionation on the intact protein level of the CSF sample mixture is necessary. For this purpose, we used either AEC or SDS-PAGE (Fig. 1 ). In the case of AEC, absorbed proteins from the immunodepleted CSF sample were eluted in a stepwise fashion with increasing concentrations of salt. An aliquot of each fraction was analyzed by SDS-PAGE in order to gauge the success of the separation (Fig. 2A) . The proteins from each salt fraction were digested and the resultant peptide mixtures subjected to two rounds of chromatography (strong cation exchange and reversed phase) and on-line tandem mass spectrometry (7) .
In the other prefractionation experiment, we loaded the immunodepleted and concentrated CSF protein mixture onto an SDS polyacrylamide gel. After electrophoresis and gel staining (Fig. 2B) , the lane containing the CSF sample was cut into 1-mm slices. Each of a total of 146 slices was then subjected to an in-gel digest followed by shotgun mass spectrometry.
For all analyses, the nano reversed phase column-eluting peptides were processed online by tandem mass spectrometry of the four strongest signals from each full scan. The MS/MS spectra acquired by the mass spectrometer were analyzed for matching peptide sequences against the human IPI protein database and a reversed sequence version of the same database using the Spectrum Mill software (9) . In the case of single peptide hits, the MS/MS spectra were further inspected manually to confirm the obtained sequence.
Processing the CSF sample by only immunodepletion and no further protein prefractionation followed by shotgun mass spectrometry resulted in 74 proteins identified. Protein separation of the immunodepleted CSF sample with the help of AEC with eight salt fractions collected yielded 112 protein hits. Prefractionation of the same sample by SDS-PAGE resulted in the most protein hits of all the analyses that were performed. A total of 240 proteins were identified from the human IPI database using default Spectrum Mill parameters (Fig. 3) . A grand total of 259 proteins were identified when data form all three methods were considered.
In order to assess the probability of false-positive hits, all MS/MS spectra were searched against a reversed sequence IPI database using the same default Spectrum Mill parameters. This allows one to obtain a fairly accurate measure of the false-positive rate of the search data. The results of both searches shown in Fig. 3 reveal that the estimated number of false-positive protein hits depends on the number of MS/MS spectra that are included in the search. Whereas a rather low percentage of false-positive protein hits was obtained for the imunodepleted analysis with no further subfractionation of the proteins (two estimated false-positive protein hits corresponding to a false-positive rate of 2.7%), the number of the estimated false-positive hits goes up slightly for data files that contain significantly more MS/MS spectra. Three and 12 protein hits were obtained when the AEC and SDS-PAGE subfractionated MS/MS data were searched against the reversed sequence IPI database, respectively. This corresponds to a false-positive rate of 4% and 5%, respectively. All false-positive hits fall in the category of "one-hit wonders"; in other words, only one peptide sequence produced the respective protein hit. A manual validation in the case of single peptide hits is therefore warranted, as there is less confidence in these assignments. No hits corresponding to "real" peptide sequences that are present in the IPI database were found during the reversed sequence IPI database search.
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Fig. 1. Cerebrospinal fluid (CSF) proteomic workflow. In all cases, CSF was immunodepleted and either underwent no further protein subfractionation, or anion exchange chromatography resulting in eight salt fractions, or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with 146 gel slice fractions. All protein fractions were further processed by enzymatic digestion followed by shotgun mass spectrometry of the peptide digest mixture. Data-dependent mass spectrometry involved a full scan followed by data-dependent tandem meass spectrometry (MS/MS) scans of the four most intense peptide ions under dynamic exclusion conditions.
The number of proteins resulting from "one-hit wonders" that were deleted from the list after manual inspection of the MS/MS spectra were 12, 3, and 0 for the SDS-PAGEsubfractionated, AEC-subfractionated, and unfractionated protein runs, respectively. These numbers are close to the predicted falsepositive rate based on the search against the reversed sequence human IPI database (Fig. 3) . A total of 46 common proteins were identified from all three runs and 95 common proteins were identified in the AEC-and SDS-PAGE-subfractionated sample runs (Table 1) . This rather low overlap of protein identifications from different runs is typical for the shotgun mass spectrometry method. In Table 1 , proteins are ranked according to the number of unique peptides that were identified for all three runs using the Spectrum Mill software. Hence, the list is a reflection of protein abundance in human CSF with high abundant proteins listed in the upper part of Table 1 .
The proteins found in normal pressure hydrocephalus CSF can be classified into several groups based on molecular function, biological process, and cellular compartment distribution ( Fig. 4 and Table 1 ). A great number of these proteins are of low abundance and in many cases represent intracellular components such as signaling proteins and transcription factors. These findings indicate that intracellular contents of cells and tissues are released into CSF, presumably through apoptotic and necrotic mechanisms.
Although it is difficult to know how many proteins are exclusively derived from the brain because many proteins are likely expressed in many tissues and therefore could potentially be introduced into CSF through its exchange with serum, we now have evidence that many of the proteins that were identified in CSF are in fact derived from brain tissue. This is based on a comparison of the identified CSF proteins with two recently published human serum protein databases (10, 11) . The comparison revealed that 122 proteins identified in our CSF analysis were also found during an indepth analysis of the human serum proteome (indicated with a bold font in the "Protein Name" column of Table 1 ). Of the 122 overlaps between CSF and serum, 15 proteins (HSA, transferrin, IgG, fibrinogen, macroglobulin, antitrypsin, C3 complement, apolipoprotein A-I, apolipoprotein, ␣-1-acid glycoprotein, complement factor H, ceruloplasmin, C9 complement, C1q complement, C8 complement) are considered to be of high abundance in serum (11) . Based on the ranking by Spectrum Mill, 5 of these proteins are also of high abundance in human CSF (macroglobulin, C3 complement, apolipoprotein A-I, complement factor H, ceruloplasmin; Table 1 ). Furthermore, 4 proteins (HSA, transferrin, IgG, antitrypsin) known to be abundant in CSF (7) had been depleted by previous immunoaffinity absorption.
As was the case in our previous analysis (7), we found proteins with a wide range of isoelectric points using the shotgun mass spectrometry approach (Fig. 5) . In order to achieve a comparable coverage of proteins with 2D-PAGE analysis, one needs to run several gels with overlapping pH gradients. This requires more sample and is often prohibitive when dealing with human body fluids and tissues. Some peptides derived from the six proteins that the Multiple Affinity Removal System was designed to remove were found in our analyses. They are most likely derived from degradation products of these proteins. One indication that this is indeed the case stems from the mobility of the protein during SDS-PAGE, which indicated a smaller molecular Fig. 3 . Results of the mass spectra data analysis using the Spectrum Mill software.The number of proteins that were identified with default search parameters for all three analyses are plotted for the human international protein index (IPI) and reversed sequence human IPI database searches. 
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Conclusions
As was anticipated at the outset of these studies, we have confirmed that extensive prefractionation of complex protein mixtures leads to an increased coverage of the sample's protein constituents. This is exemplified by using AEC or SDS-PAGE to separate CSF protein mixtures that had been previously immunodepleted of the six most abundant The proteins were identified by subjecting MS/MS data of the tryptic peptides to Spectrum Mill (9) analysis using default extraction and search parameters. The Spectrum Mill software ranks the proteins according to the number of unique peptides that were identified for all three runs. Proteins that are present in two comprehensive human serum databases (10, 11) are indicated with a bold font in the "Protein name" column.
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proteins. The subsequent shotgun mass spectrometry and protein identification analyses benefit from both the removal of abundant proteins as well as prefractionation of the CSF sample on the protein level. This is a result of the generation of a smaller dynamic range of the remaining protein mixture. In addition, because of the smaller amount of total protein that results from the combination of immunodepletion and prefractionation, a greater equivalent of the CSF sample can be used during the shotgun mass spectrometry analysis without the risk of overloading the reversedphase nano column that is used on-line with the mass spectrometer. Our previous attempts to use crude CSF (neither immunodepleted nor prefractionated) in a shotgun mass spectrometry analysis resulted in only 38 proteins that were identified as a result of the overwhelming presence of HSA, Ig, and other abundant protein-derived peptides (data not shown).
Approximately 47% of the CSF proteins that we identified were also found during indepth proteomic analyses of human serum (10, 11) . This partial overlap can be attributed to the following observations. On one hand, as discussed above, there is an inherently low overlap between shotgun analyses, especially when performed in different laboratories using different fractionation approaches and different equipment. Second, there is variability between the individuals whose body fluids were analyzed. Third, certain proteins are removed in the process of generating serum from blood and hence will not show up in the serum protein list. Finally, brainderived proteins are present in larger amounts in CSF than in serum because of the proximity of CSF and the brain and the rather low exchange between the two body fluids. The latter reason makes CSF the most relevant source for a proteomics study that is aimed at the identification of markers for brain disorders. The CSF flow rate has been recognized as the key modulator of bloodderived and brain-derived proteins in this body fluid. A close approximation of the protein portion that is derived from blood can be gained by measuring the CSF/blood albumin ratio (12) . However, at the same time, it has been shown that blood-derived proteins in CSF follow a hyperbolic function, which depends primarily on the molecular weight of the proteins (12) .
Other reports that describe attempts to analyze the CSF proteome have been published.
Most of these studies have used 2D-PAGE for sample preparation followed by mass spectrometric identification of the stained protein spots. The most detailed analysis of CSF protein constituents up to now has been performed by Sickmann et al. (13) . The analysis of over 480 protein spots from a 2D-PAGE fractionation of undepleted CSF resulted in the identification of 24 proteins from 65 spots, of which 15 were also found in our analyses. As expected, many proteins were identified multiple times because of the great number of protein isoforms found in CSF. In another report, Davidsson et al. used preparative liquid isoelectric focusing in combination with one-dimensional SDS gel electrophoresis for the identification of 32 CSF proteins, of which we identified 24 proteins in our analyses (14) . This procedure was able to identify a number of low abundant proteins in undepleted CSF samples because of the concentration in a few fractions of the abundant HSA and Ig proteins during the preparative isoelectric focusing step.
In our future studies, we will continue our CSF proteome mining efforts by trying to identify protein constituents of ever lower abundance. This will require not only the use of further fractionation steps, but, at the same time, the use of increased amounts of CSF material. Furthermore, we have begun to extend our strategies by establishing a proteomic platform that will allow us to compare the quantities of many proteins between different CSF samples. The quantitative approach will enable us to compare CSFs from different patient groups and result in the identification of patterns of proteins that are up-or downregulated, leading to important markers of brain disease.
